Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Adenocarcinoma of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06607185
What this trial is testing

The Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more
Eli Lilly and Company 750
Testing effectiveness (Phase 2)Looking for participantsNCT06333314
What this trial is testing

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

Who this might be right for
Pancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more
UNICANCER 120
Early research (Phase 1)Looking for participantsNCT05372614
What this trial is testing

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+3 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT00630552
What this trial is testing

QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasMetastatic Pancreatic CancerPancreatic Cancer
NantCell, Inc. 138
Early research (Phase 1)WithdrawnNCT04270929
What this trial is testing

Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Roger Williams Medical Center
Testing effectiveness (Phase 2)Study completedNCT00366457
What this trial is testing

Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma of the Pancreas
Massachusetts General Hospital 32
Not applicableStudy completedNCT05078775
What this trial is testing

Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma
Faeth Therapeutics 39
Testing effectiveness (Phase 2)Study completedNCT00078975
What this trial is testing

3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University Health Network, Toronto 26
Testing effectiveness (Phase 2)Study completedNCT01280058
What this trial is testing

Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Acinar Cell CarcinomaPancreatic Ductal AdenocarcinomaRecurrent Pancreatic Carcinoma+1 more
National Cancer Institute (NCI) 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT07026279
What this trial is testing

Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Metastatic
Amplia Therapeutics Limited 67
Not applicableActive Not RecruitingNCT07243288
What this trial is testing

Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy

Who this might be right for
Pancreatic CancerMeSH Term-Pancreatic Cancer, Adult)
Assistance Publique - Hôpitaux de Paris 400
Testing effectiveness (Phase 2)Study completedNCT06208124
What this trial is testing

IMM-6-415 in RAS/RAF Mutant Solid Tumors

Who this might be right for
Advanced Solid Tumor (Phase 1)Pancreas AdenocarcinomaNon-small Cell Lung Cancer+1 more
Immuneering Corporation 30
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Early research (Phase 1)Study completedNCT00003046
What this trial is testing

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Who this might be right for
Anal CancerColorectal CancerGallbladder Cancer+2 more
M.D. Anderson Cancer Center 29
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT00095966
What this trial is testing

Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT05039177
What this trial is testing

ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

Who this might be right for
Metastatic Colorectal CancerMetastatic Pancreatic Ductal Adenocarcinoma
Erasca, Inc. 101
Not applicableLooking for participantsNCT05752812
What this trial is testing

The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Medical University of Vienna 1,500
Testing effectiveness (Phase 2)Study completedNCT02826486
What this trial is testing

Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
BioLineRx, Ltd. 80
Not applicableEnded earlyNCT02072616
What this trial is testing

Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.

Who this might be right for
Circulating Tumor CellsPancreatic AdenocarcinomaCirculating Tumor DNA (KRAS)+1 more
University Hospital, Rouen 101
Next Page